Association of Serum Irisin with Metabolic Syndrome in Obese Chinese Adults

被引:138
作者
Yan, Bing [1 ,2 ]
Shi, Xiulin [2 ]
Zhang, Huijie [2 ]
Pan, Lingling [3 ]
Ma, Zhimin [4 ]
Liu, Suhuan [1 ]
Liu, Yongwen [5 ]
Li, Xiaoying [1 ,2 ,3 ]
Yang, Shuyu [1 ,2 ]
Li, Zhibin [1 ,6 ]
机构
[1] Xiamen Diabet Inst, Xiamen, Peoples R China
[2] Xiamen Univ, Affiliated Hosp 1, Dept Endocrinol & Diabet, Xiamen, Peoples R China
[3] Shanghai Jiao Tong Univ, Rui Jin Hosp, Sch Med, Shanghai Inst Endocrinol & Metab, Shanghai 200030, Peoples R China
[4] Soochow Univ, Affiliated Hosp 2, Dept Endocrinol, Suzhou, Peoples R China
[5] Xiamen Univ, Affiliated Hosp 1, Dept Nursing, Xiamen, Peoples R China
[6] Xiamen Univ, Affiliated Hosp 1, Epidemiol Res Unit, Xiamen, Peoples R China
来源
PLOS ONE | 2014年 / 9卷 / 04期
关键词
CARDIOVASCULAR-DISEASE; MORTALITY;
D O I
10.1371/journal.pone.0094235
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Irisin, a recently identified novel myokine, drives brown-fat-like conversion of white adipose tissues and has been proposed to mediate beneficial effects of exercise on metabolism. Circulating irisin was significantly reduced in type 2 diabetes patients; however, no evidence is available about its association with metabolic syndrome (MetS) and effects of adiposity and muscle mass on circulating irisin have been controversial. Cross-sectional data on socio-demographic, lifestyle, clinical characteristics and serum irisin were collected for 1,115 community-living Chinese adults with central obesity. Associations of serum irisin with MetS (central obesity plus any two of the following four factors (raised blood pressure (BP), raised fasting plasma glucose (FPG), raised triglyceride (TG), and reduced HDL cholesterol) and each component of MetS were analyzed using multivariable logistic regression. Among the 1,115 obese Chinese adults with a mean age of 53.2( +/- 7.2) years, serum irisin levels (log-transformed) were significantly reduced in subjects with MetS and raised FPG than their control groups (p = 0.034 and 0.041, respectively). After adjustment for potential confounders, serum irisin was significantly associated with reduced risks of MetS and raised FPG, with odds ratios (ORs) (95% CI) per standard deviation of log-transformed irisin of 0.796 (0.505-0.959, p = 0.027) and 0.873 (0.764-0.998, p = 0.046), respectively. Associations of irisin with raised BP, raised TG and reduced HDL were not statistically significant ((ORs) (95% CI): 0.733(0.454-1.182, p = 0.202), 0.954(0.838-1.086, p = 0.478) and 1.130(0.980-1.302, p = 0.092), respectively). Stepwise multivariable linear regression analysis showed that fasting insulin, HbA1c and albumin/ globulin ratio were negatively associated with serum irisin level with statistical significance (all p-values,0.05) and waist circumference was negatively associated with serum risin with marginally statistical significance (p = 0.055). These results imply that irisin may play an important role in insulin resistance and MetS and should be confirmed in future prospective studies.
引用
收藏
页数:10
相关论文
共 23 条
[1]   Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity [J].
Alberti, K. G. M. M. ;
Eckel, Robert H. ;
Grundy, Scott M. ;
Zimmet, Paul Z. ;
Cleeman, James I. ;
Donato, Karen A. ;
Fruchart, Jean-Charles ;
James, W. Philip T. ;
Loria, Catherine M. ;
Smith, Sidney C., Jr. .
CIRCULATION, 2009, 120 (16) :1640-1645
[2]   Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
DIABETIC MEDICINE, 2006, 23 (05) :469-480
[3]  
[Anonymous], 2019, R: A language for environment for statistical computing
[4]   A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis [J].
Bostroem, Pontus ;
Wu, Jun ;
Jedrychowski, Mark P. ;
Korde, Anisha ;
Ye, Li ;
Lo, James C. ;
Rasbach, Kyle A. ;
Bostroem, Elisabeth Almer ;
Choi, Jang Hyun ;
Long, Jonathan Z. ;
Kajimura, Shingo ;
Zingaretti, Maria Cristina ;
Vind, Birgitte F. ;
Tu, Hua ;
Cinti, Saverio ;
Hojlund, Kurt ;
Gygi, Steven P. ;
Spiegelman, Bruce M. .
NATURE, 2012, 481 (7382) :463-U72
[5]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[6]   Serum irisin levels in new-onset type 2 diabetes [J].
Choi, Yeon-Kyung ;
Kim, Mi-Kyung ;
Bae, Kwi Hyun ;
Seo, Hyun-Ae ;
Jeong, Ji-Yun ;
Lee, Won-Kee ;
Kim, Jung-Guk ;
Lee, In-Kyu ;
Park, Keun-Gyu .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 100 (01) :96-101
[7]   The metabolic syndrome [J].
Eckel, Robert H. ;
Alberti, K. G. M. M. ;
Grundy, Scott M. ;
Zimmet, Paul Z. .
LANCET, 2010, 375 (9710) :181-183
[8]   Irisin in obesity and type 2 diabetes [J].
Hojlund, Kurt ;
Bostrom, Pontus .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2013, 27 (04) :303-304
[9]   FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise [J].
Huh, Joo Young ;
Panagiotou, Grigorios ;
Mougios, Vassilis ;
Brinkoetter, Mary ;
Vamvini, Maria T. ;
Schneider, Benjamin E. ;
Mantzoros, Christos S. .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2012, 61 (12) :1725-1738
[10]   Differences between Adiposity Indicators for Predicting All-Cause Mortality in a Representative Sample of United States Non-Elderly Adults [J].
Kahn, Henry S. ;
Bullard, Kai McKeever ;
Barker, Lawrence E. ;
Imperatore, Giuseppina .
PLOS ONE, 2012, 7 (11)